NOT KNOWN DETAILS ABOUT BRD4 INHIBITION BY ABBV-744 IN CANCER RESEARCH STUDIES

Together with All those clinical trials explained previously mentioned, there have also been pre-clinical studies that showed excellent overall performance in terms of equally safety and effectiveness versus AML.In general, our current work highlights the potential utilization of ARV-825 in combination with TAM. Although ABBV-744 could also suppres